英文别名 |
Erdafitinib;N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine;Erdafitinib(JNJ-42756493);890E37NHMV;N'-(3,5-dimethoxyphenyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]-N-propan-2-ylethane-1,2-diamine;Erdafitinib [USAN:INN];Erdafitinib (USAN/INN);GTPL9039;BCP20346;s8401;compound 4 [WO2011135376];SB16854;DB12147;JNJ42756493;N-(3,5-dimethoxyphenyl;HY-18708;PAN-FGFR TYROSINE KINASE INHIBITOR JNJ-42756493;ERDAFITINIB [USAN];Erdafitinib; JNJ-42756493;Balversa;NSC781556;JNJ-42756493 (Erdafitinib);NCGC00475735-01;NSC-781556;compound 4 (WO2011135376);1,2-Ethanediamine, N1-(3,5-dimethoxyphenyl)-N2-(1-methylethyl)-N1-(3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl)-;D10927;ERDAFITINIB [MI];ERDAFITINIB [ORANGE BOOK];NS00073477;ERDAFITINIB [JAN];5SF;UNII-890E37NHMV;CS-4988;AS-35040;Erdafitinib [INN];Balversa (TN);EX-A2564;MFCD28502040;SCHEMBL2583760;Q27077213;JNJ 42756493;Erdafitinib (JAN/USAN/INN);CCG-269200;CHEMBL3545376;N-(3,5-dimethoxyphenyl)-N'-(1-methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine;BDBM50525939;erdafitinibum;GLXC-10828;1346242-81-6;DTXSID001027936;N-(3,5-dimethoxyphenyl)-3-(1-methyl-1H-pyrazol-4-yl)-N-{2-[(propan-2-yl)amino]ethyl}quinoxalin-6-amine;C25H30N6O2;JNJ-42756493;N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine; JNJ 42756493;;AC-30222;N1-(3,5-dimethoxyphenyl)-N2-isopropyl-N1-(3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl)ethane-1,2-diamine;BRD-K84868168-001-01-0;Erdafitinib?;AKOS030526429;ERDAFITINIB [WHO-DD] |